Travere’s Filspari misses the mark in key trial, but market removal looks unlikely: analysts fkansteiner Thu, 09/21/2023 – 14:09 More: Travere's Filspari misses the mark in key trial, but market removal looks unlikely: analysts Source: fierce
read moreAurinia quells investor unrest, names founder and ex-CEO Foster to its board kdunleavy Thu, 09/21/2023 – 10:26 More: Aurinia quells investor unrest, names founder and ex-CEO Foster to its board Source: fierce
read moreRoche scores—again—in hemophilia drug patent case against Takeda zbecker Thu, 09/21/2023 – 10:13 More: Roche scores—again—in hemophilia drug patent case against Takeda Source: fierce
read moreTakeda settles antitrust lawsuit over gout drug Colcrys after trial kicked off aliu Thu, 09/21/2023 – 10:00 More: Takeda settles antitrust lawsuit over gout drug Colcrys after trial kicked off Source: fierce
read moreNovo Nordisk Foundation pumps $136M into new clinical cell therapy manufacturing ‘hub’ in Denmark fkansteiner Thu, 09/21/2023 – 09:07 More: Novo Nordisk Foundation pumps 6M into new clinical cell therapy manufacturing 'hub' in Denmark Source: fierce
read moreThe report outlines ways the government can help patients with Parkinson’s disease More: Parkinson’s UK calls on government to mark World Patient Safety Day Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals